NO20083646L - Stabile doseringsformuleringer av imidazolylalkyl-pyridiner - Google Patents

Stabile doseringsformuleringer av imidazolylalkyl-pyridiner

Info

Publication number
NO20083646L
NO20083646L NO20083646A NO20083646A NO20083646L NO 20083646 L NO20083646 L NO 20083646L NO 20083646 A NO20083646 A NO 20083646A NO 20083646 A NO20083646 A NO 20083646A NO 20083646 L NO20083646 L NO 20083646L
Authority
NO
Norway
Prior art keywords
imidazolylalkyl
pyridines
dosage formulations
stable dosage
stable
Prior art date
Application number
NO20083646A
Other languages
English (en)
Inventor
Deepak S Phadke
Christian N Lavedan
Original Assignee
Vanda Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vanda Pharmaceuticals Inc filed Critical Vanda Pharmaceuticals Inc
Publication of NO20083646L publication Critical patent/NO20083646L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Stabile formuleringer av imidazolylalkylpyridiner, inkluderende formuleringer med kontrollert frigjøring.
NO20083646A 2006-02-13 2008-08-25 Stabile doseringsformuleringer av imidazolylalkyl-pyridiner NO20083646L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77272706P 2006-02-13 2006-02-13
PCT/US2007/062034 WO2007095523A2 (en) 2006-02-13 2007-02-13 Stable dosage formulations of imidazolylalkyl-pyridines

Publications (1)

Publication Number Publication Date
NO20083646L true NO20083646L (no) 2008-08-25

Family

ID=38372210

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083646A NO20083646L (no) 2006-02-13 2008-08-25 Stabile doseringsformuleringer av imidazolylalkyl-pyridiner

Country Status (12)

Country Link
US (1) US8865210B2 (no)
EP (1) EP1986659A4 (no)
JP (1) JP5044572B2 (no)
KR (1) KR20080095873A (no)
CN (1) CN101394849A (no)
AU (1) AU2007214487A1 (no)
BR (1) BRPI0707736A2 (no)
CA (1) CA2642275A1 (no)
MX (1) MX2008010322A (no)
NO (1) NO20083646L (no)
WO (1) WO2007095523A2 (no)
ZA (1) ZA200806439B (no)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4083978A (en) * 1976-01-27 1978-04-11 Egyt Gyogyszervegyeszeti Gyar Oxime ethers
DE4131584A1 (de) * 1991-09-23 1993-03-25 Sandoz Ag Imidazolylmethyl-pyridine, ihre herstellung und anwendung als pharmazeutika
US5635521A (en) 1991-09-23 1997-06-03 Sandoz Ltd. Imidazolylmethyl-pyridines
US20050244497A1 (en) 1997-11-05 2005-11-03 Wockhardt Limited Delayed delivery system for acid-sensitive drugs
US5968554A (en) * 1998-07-07 1999-10-19 Cascade Development, Inc. A Subsidiary Of Cardinal Health, Inc. Sustained release pharmaceutical preparation
US6312728B1 (en) 1998-07-07 2001-11-06 Cascade Development, Inc. Sustained release pharmaceutical preparation
US20030091632A1 (en) * 1999-08-26 2003-05-15 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US6627223B2 (en) 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems
JP2001302635A (ja) 2000-04-21 2001-10-31 Suntory Ltd 新規複素環化合物
US6979462B1 (en) 2000-10-03 2005-12-27 Mutual Pharmaceutical Co., Inc. Stabilization of solid drug formulations
US6569311B2 (en) 2001-02-02 2003-05-27 Clariant Finance (Bvi) Limited Continuous electrochemical process for preparation of zinc powder
US6500454B1 (en) * 2001-10-04 2002-12-31 Eurand Pharmaceuticals Ltd. Timed, sustained release systems for propranolol
US6663888B2 (en) 2001-12-14 2003-12-16 Eurand Pharmaceuticals Ltd. Pulsatile release histamine H2 antagonist dosage form
US8153159B2 (en) 2003-09-18 2012-04-10 Cephalon, Inc. Modafinil modified release pharmaceutical compositions
JP2005194491A (ja) 2003-12-09 2005-07-21 Mitsubishi Plastics Ind Ltd 樹脂組成物及びこれを用いた樹脂フィルム
BRPI0614701A2 (pt) 2005-07-29 2011-04-12 Vanda Pharmaceuticals Inc usos de um composto para melhorar a vigìlia e composições farmacêuticas

Also Published As

Publication number Publication date
US20090011011A1 (en) 2009-01-08
CA2642275A1 (en) 2007-08-23
EP1986659A4 (en) 2009-10-21
JP5044572B2 (ja) 2012-10-10
US8865210B2 (en) 2014-10-21
WO2007095523A3 (en) 2008-11-27
AU2007214487A1 (en) 2007-08-23
MX2008010322A (es) 2009-03-05
ZA200806439B (en) 2009-10-28
CN101394849A (zh) 2009-03-25
JP2009526783A (ja) 2009-07-23
KR20080095873A (ko) 2008-10-29
WO2007095523A2 (en) 2007-08-23
EP1986659A2 (en) 2008-11-05
BRPI0707736A2 (pt) 2011-05-10

Similar Documents

Publication Publication Date Title
CY1119974T1 (el) Στερεες μορφες 3-(5-αμινο-2-μεθυλ-4-οξο-4η-κιναζολιν-3-υλ)-πιπεριδινο-2,6-διονης και φαρμακευτικες συνθεσεις και χρησεις αυτης
DK2073811T3 (da) Kinaseinhibitorer anvendelige til behandling af myeloproliferative sygdomme og andre proliferative sygdomme
MY154898A (en) P70 s6 kinase inhibitors
BRPI0807717A2 (pt) Inibidores de quinase úteis para o tratamento de doenças mieloproliferativas e outras doenças proliferativas.
DK2240155T3 (da) Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
MX2012001974A (es) Compuestos de biarilo y metodos de uso de los mismos.
DK3461503T3 (da) Fremgangsmåder til indgivelse af tetrahydrobiopterin, associerede sammensætninger og målingsfremgangsmåder
MX2009004883A (es) Piridil sulfoximinas multi-substituidas y su uso como insecticidas.
SG179085A1 (en) Pi3 kinase inhibitors and uses thereof
MX2009007944A (es) Compuestos y composiciones de purina como inhibidores de quinasa para el tratamiento de enfermedades relacionadas con plasmodium.
IL211825A (en) Compounds based on pyridine and pyrimidine for use as wnt signal transducer inhibitors, pharmaceutical formulations containing such compounds and used as drugs for the treatment and / or cancer prevention
MX2009009428A (es) Analogos de ciclopamina heterociclicos y metodos de uso de los mismos.
SG169353A1 (en) Tamper resistant dosage forms
EA201170227A1 (ru) Имидазолкарбоксамиды
TN2010000122A1 (en) Compounds and compositions as modulators of gpr119 activity
IL177483A0 (en) Means for transdermal administration of nicotine
PL2134704T3 (pl) Związki i kompozycje pełniące rolę modulatorów aktywności GPR119
ATE553104T1 (de) Substituierte 1h-benzimidazol-4-carboxamide als potente parp-hemmer
EA201170832A1 (ru) Пуриновые соединения
ATE530170T1 (de) Paliperidonformulierung mit verzögerter freisetzung
DK2041093T3 (da) Til behandling af GPR38-receptor medierede sygdomme anvendelige piperazinylderivativer
MY167575A (en) Heterocyclic compounds and use thereof as modulators of type iii receptor tyrosine kinases
WO2011113060A3 (en) Antiviral compounds and methods of use thereof
IN2012DN02471A (no)
MX2010006206A (es) Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application